Puma Biotechnology
Los Angeles, California, United StatesFounded 2010248+ employeesPBYI
$809.3M raisedIPO· last: post ipo equity (Mar 2022)· 7 rounds
Backed by(13 investors)
At Puma Biotechnology, our focus is on bringing innovative therapies to patients to enhance cancer care. We are thankful to be part of the HER2+ breast cancer community and are passionate about evaluating options that may benefit patients across the breast cancer therapy spectrum.
